Interleukin-10 (-1082G/A) gene polymorphism in patients with type 2 diabetes with and without nephropathy

Genetic Testing and Molecular Biomarkers

Volumn 16, Issue 2, 2012, Pages 91-94

  Erdogan, Mehmet ^a   Cetinkalp, Sevki ^a   Ozgen, Ahmet Gokhan ^a   Saygili, Fusun ^a   Berdeli, Afig ^a   Yilmaz, Candeger ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; GLYCINE; INTERLEUKIN 10;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; GENE FREQUENCY; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; MUTANT; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RETROSPECTIVE STUDY; RISK ASSESSMENT; TURKEY (REPUBLIC);

ASIAN CONTINENTAL ANCESTRY GROUP; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INTERLEUKIN-10; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; TURKEY;

EID: 84856936385     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2011.0075     Document Type: Article

References (15)

1. Balakrishnan VS, Guo D, Rao M, et al.; HEMO Study Group (2004) Cytokine gene polymorphisms in hemodialysis patients: association with comorbidity, functionality, and serum albumin. Kidney Int 65:1449-1460.
2. Baylis C, Atzpodien EA, Freshour G, Engels K (2003) Peroxisome proliferator-activated receptor [gamma] agonist provides superior renal protection versus angiotensin-converting enzyme inhibition in a rat model of type 2 diabetes with obesity. J Pharmacol Exp Ther 307:854-860.
3. Chang YH, Huang CN, Wu CY, Shiau MY (2005) Association of interleukin-10 A-592C and T-819C polymorphisms with type 2 diabetes mellitus. Hum Immunol 66:1258-1263.
4. Chin HJ, Na KY, Kim SJ, et al. (2005) Interleukin-10 promoter polymorphism is associated with the predisposition to the development of IgA nephropathy and focal segmental glomerulosclerosis in Korea. J Korean Med Sci 20:989-993.
5. George S, Ruan XZ,NavarreteC, et al. (2004) Renovascular disease is associated with low producer genotypes of the anti-inflammatory cytokine interleukin-10. Tissue Antigens 63:470-475.
6. Iglesias P, Diez JJ (2006) Peroxisome proliferator-activated receptor gamma agonists in renal disease. Eur J Endocrinol 154:613-621.
7. Jeunemaitre X (2004) Genetics of diabetic complications: nephropathy. Ann Endocrinol (Paris) 65(1 Suppl):S10-S16.
8. Kahraman S, Yilmaz R, Arici M, et al. (2006) IL-10 genotype predicts serum levels of adhesion molecules, inflammation and atherosclerosis in hemodialysis patients. J Nephrol 19:50-56.
9. Mu W, Ouyang X, Agarwal A, et al. (2005) IL-10 suppresses chemokines, inflammation, and fibrosis in a model of chronic renal disease. J Am Soc Nephrol 16:v3651-v3660.
10. Mysliwska J, Zorena K, Semetkowska-Jurkiewicz E, et al. (2005) High levels of circulating interleukin-10 in diabetic nephropathy patients. Eur Cytokine Netw 16:117-122.
11. Negishi M, Shimizu H, Okada S, et al. (2004) HODE stimulates cell proliferation and extracellular matrix synthesis in human mesangial cells via PPARgamma. Exp Biol Med (Maywood) 229:1053-1060.
12. Oda K, Tanaka N, Arai T, et al. (2007) Polymorphisms in proand anti-inflammatory cytokine genes and susceptibility to atherosclerosis: a pathological study of 1,503 consecutive autopsy cases. Hum Mol Genet 16:592-599
13. Scarpelli D, Cardellini M, Andreozzi F, et al. (2006) Variants of the interleukin-10 promoter gene are associated with obesity and insulin resistance but not type 2 diabetes in Caucasian, Italian subjects. Diabetes 55:1529-1533.
14. Shpichinetsky V, Raz I, Friedlander Y, et al. (2000) The association between two common mutations C677T and A1298C in human methylenetetrahydrofolate reductase gene and the risk for diabetic nephropathy in type 2 diabetic patients. J Nutr 130:2493-2497.
15. Tsiavou A, Hatziagelaki E, Chaidaroglou A, et al. (2004) TNFalpha, TGF-beta1, IL-10, IL-6, gene polymorphisms in latent autoimmune diabetes of adults (LADA) and type 2 diabetes mellitus. J Clin Immunol 24:591-599.